Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CI&T (CINT) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for CI&T (CINT) over the last 6 years, with Q3 2025 value amounting to $43.3 million.

  • CI&T's Cash & Equivalents fell 3737.26% to $43.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.3 million, marking a year-over-year decrease of 3737.26%. This contributed to the annual value of $56.6 million for FY2024, which is 2952.3% up from last year.
  • As of Q3 2025, CI&T's Cash & Equivalents stood at $43.3 million, which was down 3737.26% from $58.6 million recorded in Q2 2025.
  • CI&T's 5-year Cash & Equivalents high stood at $72.9 million for Q1 2024, and its period low was $21.3 million during Q2 2022.
  • Its 5-year average for Cash & Equivalents is $44.4 million, with a median of $43.0 million in 2023.
  • Per our database at Business Quant, CI&T's Cash & Equivalents soared by 9082.53% in 2023 and then plummeted by 3737.26% in 2025.
  • CI&T's Cash & Equivalents (Quarter) stood at $24.3 million in 2021, then surged by 45.09% to $35.3 million in 2022, then increased by 21.09% to $42.8 million in 2023, then surged by 32.45% to $56.6 million in 2024, then dropped by 23.53% to $43.3 million in 2025.
  • Its last three reported values are $43.3 million in Q3 2025, $58.6 million for Q2 2025, and $62.8 million during Q1 2025.